3 FDA Advisory Panel Members Resign Over Agency’s Approval of Alzheimer's Drug From Biogen

3 FDA Advisory Panel Members Resign Over Agency’s Approval of Alzheimer's Drug From Biogen

Three members of an independent panel that advised the U.S. FDA on nervous system drugs had resigned after the agency approved an Alzheimer's drug from Biogen.
A First of Its Kind Alzheimer's Blood Test Goes on Sale

A First of Its Kind Alzheimer's Blood Test Goes on Sale

A new blood test claiming to detect brain plaque and help diagnose Alzheimer's disease goes on sale.
Lifestyle Changes Improve Cognition and Help People who are at risk with Alzheimer

Lifestyle Changes Improve Cognition and Help People at Risk with Alzheimer

Research shows that lifestyle change can significantly help people at risk with Alzheimer.

SALUD: Early Signs of Alzheimer's Disease Among Hispanics and Latinos

Hector M. González, Associate Professor of Epidemiology and Biostatistics at Michigan State University, recently received a $5.67 million grant from the National Institute on Aging (NIA) to fuel a study to find very early signs of Alzheimer's disease among middle-age and older Latinos.
 Alzheimer's Disease

Alzheimer's Disease Could Affect 1.3 Million Latinos by 2050

While the Latino older population is expected to triple by 2050, health experts are projecting that Latinos are disproportionately represented in the older age groups most at risk of Alzheimer's disease.

Mexican-American Seniors More Likely to Develop Alzheimer's Disease, Study Says

Alzheimer's & Dementia, a research journal, published a study which concluded that Mexican-Americans of a certain age commonly experience mild cognitive impairment (MCI), which is a memory hindrance. Mexican-Americans' risk for early Alzheimer's disease is ultimately due to the early onset of certain chronic health conditions.
Advertisement
Real Time Analytics